Clinical Outcomes Following Autologous Hematopoietic Stem Cell Transplantation with Betibeglogene Autotemcel Gene Therapy in the Phase 3 Northstar-2 and Northstar-3 Studies for Transfusiondependent b-Thalassemia (TDT)

Category Primary study
JournalHaematologica
Year 2020
This article has no abstract
Epistemonikos ID: 2a0cff0459678b235b7843851282130c71bf8139
First added on: Feb 12, 2025